Suspension of trading

Income Statement Masimo Corporation

Stocks

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 23:00:00 09/06/2026 +03			5-day change	1st Jan Change
179.95 ^USD	+0.01%		-.--%	+38.36%

08-25	Masimo Receives FDA 510(k) Clearance for Root with LiDCO and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery	CI
08-04	Masimo Appoints Tim Benner as President, Effective August 3, 2026	CI

b8f54ea.5swxtkzl-FT7tZfD4L4swS-Q4_Y_nAuHsfHKbjROXUg.pf9d8AHdz2Woxfnuhe8Yixr_sKVN3VLu5seJJlo2Liysr1P1AKPPY6HD4A

Published financial data: MASIMO CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021	2022	2023	2024	2025
Revenues	1.24B	2.04B	2.05B	2.09B	1.53B
Total Revenues	1.24B	2.04B	2.05B	2.09B	1.53B
Cost of Goods Sold, Total	431M	977M	1.04B	1.09B	583M
Gross Profit	808M	1.06B	1B	1B	944M
Selling General & Admin Expenses, Total	395M	641M	682M	754M	511M
R&D Expenses	137M	191M	175M	223M	126M
Other Operating Expenses, Total	533M	832M	857M	977M	637M
Operating Income	276M	227M	147M	27.8M	306M
Interest Expense, Total	-355K	-25.7M	-50.3M	-43.6M	-33.2M
Interest And Investment Income	936K	1.8M	3M	4.8M	3.4M
Net Interest Expenses	581K	-23.9M	-47.3M	-38.8M	-29.8M
Currency Exchange Gains (Loss)	-1.86M	7.3M	-1.1M	200K	-7.6M
Other Non Operating Income (Expenses)	-160K	-	-	-	-
EBT, Excl. Unusual Items	274M	210M	98.3M	-10.8M	269M
Restructuring Charges	-	-	-	-	1.5M
Merger & Related Restructuring Charges	-	-16.6M	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-10M	-304M	-
Insurance Settlements	-	-	17.6M	10M	4.8M
Legal Settlements	-	-	-17.8M	-500K	-2.8M
EBT, Incl. Unusual Items	274M	193M	88.1M	-305M	273M
Income Tax Expense	44.73M	49.9M	6.6M	-400K	64.9M
Earnings From Continuing Operations	230M	144M	81.5M	-305M	208M
Earnings Of Discontinued Operations	-	-	-	-	-359M
Net Income to Company	230M	144M	81.5M	-305M	-152M
Minority Interest	-	-	-	-	-
Net Income - (IS)	230M	144M	81.5M	-305M	-152M
Net Income to Common Incl Extra Items	230M	144M	81.5M	-305M	-152M
Net Income to Common Excl. Extra Items	230M	144M	81.5M	-305M	208M
Per Share Items
Net EPS - Basic	4.16	2.68	1.54	-5.72	-2.83
Basic EPS - Continuing Operations	4.16	2.68	1.54	-5.72	3.88
Basic Weighted Average Shares Outstanding	55.17M	53.6M	52.8M	53.3M	53.6M
Net EPS - Diluted	3.98	2.6	1.51	-5.72	-2.8
Diluted EPS - Continuing Operations	3.98	2.6	1.51	-5.72	3.83
Diluted Weighted Average Shares Outstanding	57.68M	55.2M	54.1M	53.3M	54.2M
Normalized Basic EPS	3.11	2.45	1.16	-0.13	3.14
Normalized Diluted EPS	2.97	2.38	1.14	-0.13	3.1
Supplemental Items
EBITDA	311M	358M	226M	131M	345M
EBITA	286M	266M	201M	89.5M	320M
EBIT	276M	227M	147M	27.8M	306M
EBITDAR	320M	376M	248M	156M	354M
Total Revenues (As Reported)	1.24B	-	-	2.09B	1.53B
Effective Tax Rate - (Ratio)	16.3	25.8	7.49	0.13	23.81
Current Domestic Taxes	45.24M	54.8M	18.5M	18.4M	27.6M
Current Foreign Taxes	14.58M	34.4M	23.7M	19.4M	25.5M
Total Current Taxes	59.82M	89.2M	42.2M	37.8M	53.1M
Deferred Domestic Taxes	-10.94M	-29.2M	-21.5M	-27.3M	12.5M
Deferred Foreign Taxes	-4.15M	-10.1M	-14.1M	-10.9M	-700K
Total Deferred Taxes	-15.09M	-39.3M	-35.6M	-38.2M	11.8M
Normalized Net Income	171M	131M	61.44M	-6.75M	168M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	300K	25.7M	47M	41.2M	33.2M
Non-Cash Pension Expense	-	-100K	-200K	-300K	-300K
Supplemental Operating Expense Items
Advertising Expense	9M	12.3M	61.4M	-	-
Marketing Expenses	-	-	-	58.2M	9.4M
Selling and Marketing Expenses	9M	12.3M	61.4M	58.2M	9.4M
Research And Development Expense From Footnotes	137M	191M	175M	223M	126M
Net Rental Expense, Total	8.2M	18M	22.7M	25.7M	8.5M
Imputed Operating Lease Interest Expense	695K	6.97M	9.14M	9.87M	3.42M
Imputed Operating Lease Depreciation	7.5M	11.03M	13.56M	15.83M	5.08M
Stock-Based Comp., COGS (Total)	839K	1M	1.1M	1M	700K
Stock-Based Comp., R&D Exp. (Total)	12.47M	13.8M	7.4M	15.3M	13.2M
Stock-Based Comp., SG&A Exp. (Total)	31.32M	32.9M	-1.5M	25.2M	21.9M
Total Stock-Based Compensation	44.62M	47.7M	7M	41.5M	35.8M

Fiscal Period: January	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	745M	203M	163M	178M	152M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	745M	203M	163M	178M	152M
Accounts Receivable, Total	232M	478M	392M	449M	292M
Other Receivables	12.85M	26.8M	28.6M	40M	35.8M
Notes Receivable	-	-	-	-	-
Total Receivables	245M	505M	421M	489M	328M
Inventory	201M	501M	545M	459M	380M
Prepaid Expenses	33.66M	81.2M	63.1M	41.2M	45.9M
Restricted Cash	3.04M	2.4M	3M	2.7M	-
Other Current Assets, Total	10.4M	16M	36.8M	55.8M	20M
Total Current Assets	1.24B	1.31B	1.23B	1.23B	926M
Gross Property Plant And Equipment	476M	710M	795M	812M	732M
Accumulated Depreciation	-173M	-238M	-311M	-356M	-344M
Net Property Plant And Equipment	303M	472M	484M	456M	388M
Long-term Investments	13.83M	13.8M	9.9M	8.6M	5.9M
Goodwill	100M	445M	408M	96.7M	101M
Other Intangibles, Total	72.5M	723M	652M	558M	52.1M
Accounts Receivable Long-Term	78.66M	82.5M	88.4M	78.9M	64.4M
Deferred Tax Assets Long-Term	52.61M	102M	107M	144M	114M
Deferred Charges Long-Term	11.88M	17.1M	21.8M	25M	26.2M
Other Long-Term Assets, Total	15.51M	46M	38.8M	32.9M	21.4M
Total Assets	1.89B	3.21B	3.04B	2.63B	1.7B
Liabilities
Accounts Payable, Total	75.63M	277M	252M	253M	103M
Accrued Expenses, Total	125M	223M	170M	205M	180M
Current Portion of Long-Term Debt	-	15.1M	34.3M	37.3M	6.3M
Current Portion of Leases	6.37M	18.7M	18.2M	21.4M	8.1M
Current Income Taxes Payable	12M	32.1M	16.1M	18.4M	16.7M
Unearned Revenue Current, Total	29.82M	36M	37.4M	46.8M	38.5M
Other Current Liabilities	18.47M	28.1M	35.9M	35.8M	19.5M
Total Current Liabilities	268M	630M	564M	618M	372M
Long-Term Debt	-	942M	872M	728M	518M
Long-Term Leases	26.29M	53.4M	45.8M	59.5M	26.9M
Unearned Revenue Non Current	5.3M	25M	26.4M	27.4M	23M
Pension & Other Post Retirement Benefits	-	10.1M	9.5M	9M	5.5M
Deferred Tax Liability Non Current	5.11M	164M	112M	100M	200K
Other Non Current Liabilities	32.32M	48M	47.8M	32.2M	32.5M
Total Liabilities	337M	1.87B	1.68B	1.57B	978M
Common Stock, Total	55K	100K	100K	100K	100K
Additional Paid In Capital	753M	782M	783M	838M	929M
Retained Earnings	1.57B	1.71B	1.8B	1.49B	1.34B
Treasury Stock	-768M	-1.17B	-1.17B	-1.17B	-1.53B
Comprehensive Income and Other	-5.53M	11.5M	-45.3M	-108M	-12.5M
Total Common Equity	1.55B	1.34B	1.36B	1.05B	721M
Minority Interest	-	-	-	-	-
Total Equity	1.55B	1.34B	1.36B	1.05B	721M
Total Liabilities And Equity	1.89B	3.21B	3.04B	2.63B	1.7B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	55.36M	52.6M	52.91M	53.95M	52.19M
ECS Total Common Shares Outstanding	55.34M	52.5M	52.8M	53.6M	52.1M
Book Value / Share	28.02	25.5	25.85	19.62	13.84
Tangible Book Value	1.38B	171M	305M	397M	568M
Tangible Book Value Per Share	24.89	3.26	5.77	7.41	10.9
Total Debt	32.66M	1.03B	970M	846M	559M
Net Debt	-713M	826M	807M	668M	407M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	10.1M	9.5M	9M	5.5M
Debt Equivalent Oper. Leases	65.6M	144M	182M	206M	68M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	128M	210M	230M	181M	153M
Inventories - Work In Process, Total	17.14M	30.4M	30M	24.3M	21.8M
Inventories - Finished Goods, Total	55.91M	261M	285M	254M	206M
Land - (BS)	57.03M	65.1M	66.2M	54.3M	47.7M
Buildings, Total	142M	151M	151M	150M	152M
Machinery, Total	184M	255M	281M	253M	209M
Full Time Employees	2.2K	4K	3.8K	3.6K	2.2K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Assets on Operating Lease - Gross	-	-	-	149M	204M
Accumulated Allowance for Doubtful Accounts (Supple)	2.18M	7.7M	4.8M	5.2M	4.5M

Fiscal Period: January	2021	2022	2023	2024	2025
Net Income	230M	144M	81.5M	-305M	-152M
Depreciation & Amortization - CF	25.32M	96.3M	43.9M	41.3M	25.5M
Amortization of Goodwill and Intangible Assets - (CF)	10.3M	39.8M	54.4M	61.7M	13.3M
Depreciation & Amortization, Total	35.62M	136M	98.3M	103M	38.8M
Amortization of Deferred Charges, Total - (CF)	-	1.4M	1.9M	1.9M	3M
(Gain) Loss From Sale Of Asset	479K	500K	800K	-	-
Asset Writedown & Restructuring Costs	-	-	10M	304M	-
Stock-Based Compensation (CF)	44.62M	47.7M	7M	41.5M	35.8M
Provision and Write-off of Bad Debts	815K	1.3M	1.1M	1.1M	3M
Net Cash From Discontinued Operations	-	-	-	-	600K
Other Operating Activities, Total	-15.09M	-39.3M	-35.6M	60.5M	378M
Change In Accounts Receivable	-60.8M	-138M	90.2M	-65M	2.2M
Change In Inventories	13.49M	-156M	-69.2M	-7.5M	-112M
Change In Accounts Payable	10.99M	60.5M	-19.6M	14.8M	-27.1M
Change in Unearned Revenues	7.11M	28.1M	7.1M	10.3M	3.7M
Change In Income Taxes	6.41M	3.8M	-15.1M	2.2M	3.9M
Change in Other Net Operating Assets	-8.55M	-59.8M	-64.3M	34.5M	39.5M
Cash from Operations	265M	29.4M	94.1M	196M	218M
Capital Expenditure	-25.5M	-52.8M	-44M	-20M	-19.4M
Sale of Property, Plant, and Equipment	-	-	-	-	19.6M
Cash Acquisitions	-	-1B	7.5M	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-9.43M	-3.5M	-43.7M	-31.1M	-5.3M
Investment in Marketable and Equity Securities, Total	-2.6M	-1.7M	-	-	-
Other Investing Activities, Total	-	-	-1M	-100K	280M
Cash from Investing	-37.53M	-1.06B	-81.2M	-51.2M	275M
Long-Term Debt Issued, Total	-	1.08B	189M	98.8M	1.08B
Total Debt Issued	-	1.08B	189M	98.8M	1.08B
Long-Term Debt Repaid, Total	-	-135M	-240M	-238M	-1.28B
Total Debt Repaid	-	-135M	-240M	-238M	-1.28B
Issuance of Common Stock	23.24M	8.1M	7M	25.2M	71.4M
Repurchase of Common Stock	-146M	-427M	-12.9M	-11.8M	-382M
Other Financing Activities, Total	-	-9.3M	-	-	-6.3M
Cash from Financing	-122M	520M	-57.1M	-126M	-521M
Foreign Exchange Rate Adjustments	-1.45M	-30.9M	2.8M	-6.4M	-300K
Net Change in Cash	103M	-539M	-41.4M	13.2M	-28.1M
Supplemental Items
Cash Interest Paid	285K	23M	51M	39.1M	32.8M
Cash Income Tax Paid (Refund)	43.95M	87.3M	54.4M	41.9M	28.5M
Levered Free Cash Flow	218M	-23.14M	31.65M	154M	316M
Unlevered Free Cash Flow	218M	-8.48M	61.19M	179M	334M
Change In Net Working Capital	-60K	278M	48.1M	-68.4M	-92.7M
Net Debt Issued / Repaid	-	948M	-51.2M	-139M	-204M

Fiscal Period: January	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.58	5.56	2.93	0.61	8.86
Return on Total Capital	11.4	7.17	3.9	0.82	12.38
Return On Equity %	15.53	9.93	6.03	-25.23	23.43
Return on Common Equity	15.53	9.93	6.03	-25.23	23.43
Margin Analysis
Gross Profit Margin %	65.23	52.01	49	47.96	61.8
SG&A Margin	31.9	31.48	33.28	35.99	33.45
EBITDA Margin %	25.13	17.6	11.02	6.25	22.61
EBITA Margin %	23.09	13.09	9.82	4.27	20.94
EBIT Margin %	22.26	11.13	7.16	1.33	20.07
Income From Continuing Operations Margin %	18.53	7.05	3.98	-14.56	13.6
Net Income Margin %	18.53	7.05	3.98	-14.56	-9.92
Net Avail. For Common Margin %	18.53	7.05	3.98	-14.56	13.6
Normalized Net Income Margin	13.84	6.45	3	-0.32	11.01
Levered Free Cash Flow Margin	17.56	-1.14	1.55	7.34	20.72
Unlevered Free Cash Flow Margin	17.57	-0.42	2.99	8.55	21.88
Asset Turnover
Asset Turnover	0.69	0.8	0.66	0.74	0.71
Fixed Assets Turnover	4.08	5.25	4.29	4.46	4.05
Receivables Turnover (Average Receivables)	6.22	5.74	4.7	5.02	5.1
Inventory Turnover (Average Inventory)	2.06	2.78	2	2.17	1.73
Short Term Liquidity
Current Ratio	4.63	2.08	2.18	1.98	2.49
Quick Ratio	3.7	1.12	1.04	1.08	1.29
Operating Cash Flow to Current Liabilities	0.99	0.05	0.17	0.32	0.59
Days Sales Outstanding (Average Receivables)	58.56	63.46	77.37	72.51	72.72
Days Outstanding Inventory (Average Inventory)	176.3	130.85	182.24	167.67	214.73
Average Days Payable Outstanding	61.08	50.24	88.32	91.4	64.36
Cash Conversion Cycle (Average Days)	173.78	144.07	171.29	148.78	223.1
Long Term Solvency
Total Debt/Equity	2.11	76.84	71.07	80.44	77.55
Total Debt / Total Capital	2.06	43.45	41.55	44.58	43.68
LT Debt/Equity	1.7	74.31	67.23	74.86	75.55
Long-Term Debt / Total Capital	1.66	42.02	39.3	41.49	42.55
Total Liabilities / Total Assets	17.85	58.3	55.13	59.94	57.55
EBIT / Interest Expense	776.96	8.82	2.92	0.64	9.23
EBITDA / Interest Expense	900.4	14.64	4.94	3.59	10.66
(EBITDA - Capex) / Interest Expense	828.56	12.59	4.06	3.13	10.07
Total Debt / EBITDA	0.1	2.73	3.9	5.41	1.58
Net Debt / EBITDA	-2.23	2.19	3.25	4.27	1.15
Total Debt / (EBITDA - Capex)	0.11	3.18	4.75	6.2	1.67
Net Debt / (EBITDA - Capex)	-2.42	2.55	3.95	4.9	1.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.34	64.28	0.6	2.26	9.44
Gross Profit, 1 Yr. Growth %	8.79	30.97	-5.22	0.09	16.64
EBITDA, 1 Yr. Growth %	9.41	15.25	-37.01	-50.19	78.17
EBITA, 1 Yr. Growth %	8.85	-6.89	-24.51	-59.08	95.36
EBIT, 1 Yr. Growth %	8.02	-17.84	-35.26	-83.08	110.94
Earnings From Cont. Operations, 1 Yr. Growth %	-4.43	-37.5	-43.21	-474.11	1.18K
Net Income, 1 Yr. Growth %	-4.43	-37.5	-43.21	-474.11	-50.31
Normalized Net Income, 1 Yr. Growth %	4.22	-23.47	-53.19	-109.32	158.5
Diluted EPS Before Extra, 1 Yr. Growth %	-3.86	-34.67	-41.92	-478.84	1.18K
Accounts Receivable, 1 Yr. Growth %	38.96	106.52	-17.96	16.67	-4.95
Inventory, 1 Yr. Growth %	-6.75	148.76	8.78	-15.74	29
Net Property, Plant and Equip., 1 Yr. Growth %	-0.51	55.65	2.41	-5.69	5.87
Total Assets, 1 Yr. Growth %	10.19	70.14	-5.27	-13.67	-35.3
Tangible Book Value, 1 Yr. Growth %	11.94	-87.59	78.35	30.25	-36.43
Common Equity, 1 Yr. Growth %	10.13	-13.63	1.93	-22.93	-31.44
Cash From Operations, 1 Yr. Growth %	25.5	-88.89	220.07	108.71	10.9
Capital Expenditures, 1 Yr. Growth %	-64.85	107.06	-16.67	-54.55	-8.06
Levered Free Cash Flow, 1 Yr. Growth %	263.16	-110.64	-236.79	260.67	95.72
Unlevered Free Cash Flow, 1 Yr. Growth %	262.26	-103.89	-821.98	148.21	80.13
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.95	33.42	28.56	1.43	9.41
Gross Profit, 2 Yr. CAGR %	13.35	19.37	11.42	-2.6	10.67
EBITDA, 2 Yr. CAGR %	12.82	12.28	-14.8	-39.95	23.17
EBITA, 2 Yr. CAGR %	12.61	0.68	-16.16	-42.04	27.02
EBIT, 2 Yr. CAGR %	11.66	-5.79	-27.07	-64.97	27.45
Earnings From Cont. Operations, 2 Yr. CAGR %	8.18	-22.72	-40.42	45.76	38.87
Net Income, 2 Yr. CAGR %	8.18	-22.72	-40.42	45.76	36.34
Normalized Net Income, 2 Yr. CAGR %	8.25	-10.68	-40.15	-77.32	40.82
Diluted EPS Before Extra, 2 Yr. CAGR %	7.56	-20.75	-38.4	48.33	38.73
Accounts Receivable, 2 Yr. CAGR %	21.31	69.32	30.17	-3.08	-12.97
Inventory, 2 Yr. CAGR %	31.83	52.31	64.5	-4.26	-16.47
Net Property, Plant and Equip., 2 Yr. CAGR %	12.72	24.45	26.26	-1.72	-10.45
Total Assets, 2 Yr. CAGR %	16.26	36.92	26.96	-9.57	-25.26
Tangible Book Value, 2 Yr. CAGR %	10.98	-62.73	-52.96	52.41	36.52
Common Equity, 2 Yr. CAGR %	15.21	-2.47	-6.17	-11.36	-27.31
Cash From Operations, 2 Yr. CAGR %	9.29	-62.68	-40.37	158.46	52.14
Capital Expenditures, 2 Yr. CAGR %	-38.93	-14.66	31.36	-38.45	-28.92
Levered Free Cash Flow, 2 Yr. CAGR %	67.32	-37.86	-61.86	157.84	252.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	67.18	-62.45	-46.99	359.8	151.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.02	29.48	21.44	19.12	-9.14
Gross Profit, 3 Yr. CAGR %	12.03	18.95	10.54	7.5	-3.76
EBITDA, 3 Yr. CAGR %	10.7	13.55	-7.39	-25.07	-1.63
EBITA, 3 Yr. CAGR %	10.29	5.7	-8.53	-32.12	6.28
EBIT, 3 Yr. CAGR %	9.78	0.8	-16.86	-53.46	10.59
Earnings From Cont. Operations, 3 Yr. CAGR %	5.87	-9.9	-30.26	9.92	13.12
Net Income, 3 Yr. CAGR %	5.87	-9.9	-30.26	9.92	1.82
Normalized Net Income, 3 Yr. CAGR %	8.6	-3.57	-27.99	-65.98	8.62
Diluted EPS Before Extra, 3 Yr. CAGR %	4.88	-8.91	-28.55	12.85	13.78
Accounts Receivable, 3 Yr. CAGR %	26.92	44.8	32.99	24.72	-15.2
Inventory, 3 Yr. CAGR %	28.58	62.91	36.15	31.62	-8.78
Net Property, Plant and Equip., 3 Yr. CAGR %	22.26	25.53	16.62	14.56	-6.35
Total Assets, 3 Yr. CAGR %	17.78	31.99	21.1	11.64	-19.12
Tangible Book Value, 3 Yr. CAGR %	14.49	-46.54	-37.2	-33.94	49.24
Common Equity, 3 Yr. CAGR %	16.95	4.66	-1.02	-12.13	-18.64
Cash From Operations, 3 Yr. CAGR %	3.39	-49	-23.61	-9.46	94.94
Capital Expenditures, 3 Yr. CAGR %	14.19	-8.26	-15.33	-7.78	-28.38
Levered Free Cash Flow, 3 Yr. CAGR %	6.47	-33.22	-19.17	-10.91	139.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.42	-52.26	0.59	-6.29	240.36
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.69	20.84	19	17.43	5.95
Gross Profit, 5 Yr. CAGR %	11.06	15.19	11.79	9.81	4.9
EBITDA, 5 Yr. CAGR %	11.47	11.94	-0.34	-11.77	3.97
EBITA, 5 Yr. CAGR %	11.24	7.14	-1.17	-16.88	4
EBIT, 5 Yr. CAGR %	10.7	4.28	-6.79	-33.95	3.72
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.89	2.83	-15.88	9.22	-2.87
Net Income, 5 Yr. CAGR %	-5.89	2.83	-15.88	9.22	-8.81
Normalized Net Income, 5 Yr. CAGR %	10.91	2.48	-14.43	-45.95	0.44
Diluted EPS Before Extra, 5 Yr. CAGR %	-7.41	3.12	-15.23	10.71	-1.54
Accounts Receivable, 5 Yr. CAGR %	16.26	30.02	28.18	23.32	11.82
Inventory, 5 Yr. CAGR %	22.65	40.27	41.9	31.71	11.98
Net Property, Plant and Equip., 5 Yr. CAGR %	17.4	23.53	23.84	13.82	4.93
Total Assets, 5 Yr. CAGR %	18.12	28.81	21.37	13.47	-0.16
Tangible Book Value, 5 Yr. CAGR %	21.93	-24.05	-19.79	-18.71	-14.32
Common Equity, 5 Yr. CAGR %	22.58	13.08	7.09	-2.07	-12.52
Cash From Operations, 5 Yr. CAGR %	-8.78	-12.11	-17.04	-2.39	0.63
Capital Expenditures, 5 Yr. CAGR %	5.29	3.86	20.77	-21.8	-23.18
Levered Free Cash Flow, 5 Yr. CAGR %	6.34	-4.32	-29.38	14.63	39.48
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.1	-21.5	-19.47	18.12	40.93